Webinar Information and Registration
Ask the Expert:
Strategies for Optimizing Antimicrobial Use in ABSSSI and CABP
Tuesday, March 25, 2014
1-2 pm EST
After registration, you will receive an e-mail confirmation with instructions for joining the webinar.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-14-463-L01-P).
This activity is provided free of charge. Participants must participate in the entire presentation, submit an enrollment code (announced during the webinar), and complete the course evaluation to receive continuing pharmacy education (CPE) credit. Participants will process CPE credit online at http://elearning.ashp.org/my-activities, with the option of printing a CPE certificate. CPE credit will be reported directly to CPE Monitor. View full CE processing instructions.
Methods and Format
This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool. A live webinar brings the presentation to you. Listen to the speaker present in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, ambulatory care clinics, managed care organizations, and academia. This activity would be particularly beneficial for pharmacists, clinical specialists, pharmacy managers, leaders, and educators who are interested in infectious diseases.
This activity will focus factors integral to optimizing use of antimicrobials for acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). Evidence based guidelines and recommendations will be reviewed, and guidance for incorporating antimicrobial stewardship principles into decision making processes for selecting therapies for both empiric and targeted therapies will be emphasized. Particular emphasis will be placed on delineating the role of newer antibiotics that have gained FDA approval for ABSSSI and CABP since the most recent version of consensus treatment guidelines have been published.
After participating in this application-based educational activity, attendees should be able to
- Compare and contrast at least one new FDA approved agent to current guideline endorsed therapies for ABSSSI and for CABP.
- Choose a first-line therapy and an alternative therapy recommendation for ABSSSI and CABP that are suitable for an institutional clinical pathway.
John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair
Assistant Professor, Pharmacy Practice
Chicago State University College of Pharmacy
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
John Esterly, Pharm.D., BCPS (AQ-ID), is Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy (CSU-COP) and Infectious Diseases Pharmacist at Northwestern Memorial Hospital in Chicago, Illinois. In these roles Dr. Esterly practices as a clinical pharmacist, specializing in the area of infectious diseases. He is also an integral member of the Antimicrobial Stewardship Program at Northwestern Memorial Hospital.
Dr. Esterly received his Doctor of Pharmacy degree from the University of Illinois-Chicago College of Pharmacy. He completed a pharmacy practice residency with comprehensive pharmacy services at Mercy Hospital and Medical Center in Chicago, Illinois. Dr. Esterly then completed a two-year infectious diseases pharmacotherapy fellowship with the Midwestern University Chicago College of Pharmacy in conjunction with Northwestern Memorial Hospital and Rush University Medical Center in Chicago, Illinois. He is a board certified pharmacotherapy specialist with added qualifications in infectious diseases.
Dr. Esterly’s research interests include antimicrobial resistance, pharmacokinetics and pharmacodynamics of antimicrobials, and antimicrobial stewardship related outcomes. His work has been presented at several national meetings and has been published in peer-reviewed journals. He also serves as a peer reviewer for both infectious diseases and pharmacy medical journals.
Viewing the Webinar as a Group
To arrange for colleagues to participate in this webinar as a group, one person serving as the group coordinator should register for the webinar. The group coordinator will receive an e-mail confirmation with instructions for joining the webinar. A few minutes before the webinar begins, the group coordinator should launch the webinar link. Once the webinar has been activated, the coordinator will have the option to open the audio via VoIP (Voice Over IP) on the webinar toolbar or use a touch tone phone with the provided dial-in information. At the conclusion of the activity, the group coordinator will complete a brief online evaluation and report the number of participants at that site. Each participant will process their own continuing education statements online.
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.
Planned and conducted by ASHP Advantage and supported by an educational grant from Forest Research Institute, a subsidiary of Forest Laboratories, Inc.